Pandemic preparedness: A new report has sounded the alarm on the urgent need to address global disparities and foster interdisciplinary cooperation to effectively prepare for and respond to future pandemics.
Jane Kinghorn, Director at UCL Translational Research Office and Nick McNally, Managing Director Research UCL/UCLH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group sheds light on the spread and expansion of several types of the influenza virus in Africa.
Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.
The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.
A group of experts from the World Health Organization explain the Global Influenza Strategy for 2019-2030 that charts the path towards greater global influenza prevention, control, and preparedness through 2030.
Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.
Steve Sawyer, managing director of Access Health & Social Care, explains how technology is helping care providers to protect the safety of frontline care workers during the COVID-19 pandemic.
Here, a group of seasoned experts discusses the important role of prevention and reduction of mental stress in the general population and in sensitive groups in the context of the COVID-19 pandemic.
Countries like Hong Kong and South Korea have been tracing their potential infection sources since January: How will the UK implement an Asian COVID strategy?
Nina Lindfors, Director of Teaching and Research at Helsinki University Hospital, illuminates us about a new approach to infection treatment that concerns an antibacterial bioactive glass for bone reconstruction.
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, underlines the WHO’s annual Clean Your Hands campaign and comments on harmonisation in hand hygiene training to help prevent and control infections.
